230 related articles for article (PubMed ID: 35210398)
1. Multi-omic characterization of genome-wide abnormal DNA methylation reveals diagnostic and prognostic markers for esophageal squamous-cell carcinoma.
Xi Y; Lin Y; Guo W; Wang X; Zhao H; Miao C; Liu W; Liu Y; Liu T; Luo Y; Fan W; Lin A; Chen Y; Sun Y; Ma Y; Niu X; Zhong C; Tan W; Zhou M; Su J; Wu C; Lin D
Signal Transduct Target Ther; 2022 Feb; 7(1):53. PubMed ID: 35210398
[TBL] [Abstract][Full Text] [Related]
2. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
[TBL] [Abstract][Full Text] [Related]
3. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
[TBL] [Abstract][Full Text] [Related]
4. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma.
Ma K; Cao B; Guo M
Clin Epigenetics; 2016; 8():43. PubMed ID: 27110300
[TBL] [Abstract][Full Text] [Related]
5. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma.
Guo W; Dong Z; Shi Y; Liu S; Liang J; Guo Y; Guo X; Shen S; Shan B
Dig Liver Dis; 2016 Aug; 48(8):961-9. PubMed ID: 27338851
[TBL] [Abstract][Full Text] [Related]
7. Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis.
Li X; Zhou F; Jiang C; Wang Y; Lu Y; Yang F; Wang N; Yang H; Zheng Y; Zhang J
PLoS One; 2014; 9(7):e103162. PubMed ID: 25050929
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.
Nagata H; Kozaki KI; Muramatsu T; Hiramoto H; Tanimoto K; Fujiwara N; Imoto S; Ichikawa D; Otsuji E; Miyano S; Kawano T; Inazawa J
Oncotarget; 2017 Jun; 8(23):37740-37750. PubMed ID: 28465481
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.
Ling ZQ; Li P; Ge MH; Hu FJ; Fang XH; Dong ZM; Mao WM
Dig Dis Sci; 2011 Oct; 56(10):2992-3004. PubMed ID: 21674174
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma.
Chen C; Peng H; Huang X; Zhao M; Li Z; Yin N; Wang X; Yu F; Yin B; Yuan Y; Lu Q
Oncotarget; 2016 Jan; 7(4):4507-21. PubMed ID: 26683359
[TBL] [Abstract][Full Text] [Related]
11. A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma.
Chang WL; Lai WW; Kuo IY; Lin CY; Lu PJ; Sheu BS; Wang YC
J Gastroenterol; 2017 Jun; 52(6):705-714. PubMed ID: 27671002
[TBL] [Abstract][Full Text] [Related]
12. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
[TBL] [Abstract][Full Text] [Related]
14. Screening aberrant methylation profile in esophageal squamous cell carcinoma for Kazakhs in Xinjiang area of China.
Chen Y; Yin D; Li L; Deng YC; Tian W
Mol Biol Rep; 2015 Feb; 42(2):457-64. PubMed ID: 25304811
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide methylation profiling identify hypermethylated HOXL subclass genes as potential markers for esophageal squamous cell carcinoma detection.
Yu Q; Xia N; Zhao Y; Jin H; Chen R; Ye F; Chen L; Xie Y; Wan K; Zhou J; Zhou D; Lv X
BMC Med Genomics; 2022 Nov; 15(1):247. PubMed ID: 36447287
[TBL] [Abstract][Full Text] [Related]
16. Network-based analysis identifies epigenetic biomarkers of esophageal squamous cell carcinoma progression.
Cheng CP; Kuo IY; Alakus H; Frazer KA; Harismendy O; Wang YC; Tseng VS
Bioinformatics; 2014 Nov; 30(21):3054-61. PubMed ID: 25015989
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA CCAT2 correlates with smoking in esophageal squamous cell carcinoma.
Wang J; Qiu M; Xu Y; Li M; Dong G; Mao Q; Yin R; Xu L
Tumour Biol; 2015 Jul; 36(7):5523-8. PubMed ID: 25677908
[TBL] [Abstract][Full Text] [Related]
19. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma.
Adams L; Roth MJ; Abnet CC; Dawsey SP; Qiao YL; Wang GQ; Wei WQ; Lu N; Dawsey SM; Woodson K
Cancer Prev Res (Phila); 2008 Oct; 1(5):357-61. PubMed ID: 19137073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
